Close

Analyst Ratings for Champions Oncology (CSBR) [Buys]

CSBR Rating Summary

CSBR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CSBR
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.25 (+48.1%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/20/2019 Roth/MKM
» Updated 9/22/2023
Scott Henry New Coverage Buy
(N/A)
7.50
(9.00)
6.08
(5.57)
-8.39% Details
2/27/2019 National Securities N/A New Coverage Buy
(N/A)
17.00
(N/A)
9.54
(5.57)
-41.61% Details